Beta-3 Enhanced Autonomic Therapy for POTS

Clinical trial NCT07585513 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07585513
Sponsor: Cedars-Sinai Medical Center
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Postural Orthostatic Tachycardia Syndrome (POTS)

Start date: 2026-05-01
Primary completion: 2028-05-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.